The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of prostaglandin formation in inflammatory states, and COX-2 overexpression plays a key role in carcinogenesis. To understand the mechanisms regulating COX-2 expression, we examined its posttranscriptional regulation mediated through the AU-rich element (ARE) within the COX-2 mRNA 3′-untranslated region (3′UTR). RNA binding studies, performed to identify ARE-binding regulatory factors, demonstrated binding of the translational repressor protein TIA-1 to COX-2 mRNA. The significance of TIA-1-mediated regulation of COX-2 expression was observed in TIA-1 null fibroblasts that produced significantly more COX-2 protein than wild-type fibroblasts. However, TIA-1 deficiency did not alter COX-2 transcription or mRNA turnover. Colon cancer cells demonstrated to overexpress COX-2 through increased polysome association with COX-2 mRNA also showed defective TIA-1 binding both in vitro and in vivo. These findings implicate that TIA-1 functions as a translational silencer of COX-2 expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
Skip Nav Destination
Article navigation
4 August 2003
Brief Definitive Report|
July 28 2003
Regulation of Cyclooxygenase-2 Expression by the Translational Silencer TIA-1
Dan A. Dixon,
Dan A. Dixon
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Search for other works by this author on:
Glen C. Balch,
Glen C. Balch
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Search for other works by this author on:
Nancy Kedersha,
Nancy Kedersha
4Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115
Search for other works by this author on:
Paul Anderson,
Paul Anderson
4Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115
Search for other works by this author on:
Guy A. Zimmerman,
Guy A. Zimmerman
2Eccles Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT 84112
Search for other works by this author on:
R. Daniel Beauchamp,
R. Daniel Beauchamp
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Search for other works by this author on:
Stephen M. Prescott
Stephen M. Prescott
3Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112
Search for other works by this author on:
Dan A. Dixon
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Glen C. Balch
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Nancy Kedersha
4Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115
Paul Anderson
4Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115
Guy A. Zimmerman
2Eccles Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT 84112
R. Daniel Beauchamp
1Surgical Oncology Research Laboratory, Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
Stephen M. Prescott
3Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112
Address correspondence to Dan A. Dixon, Surgical Oncology Research Laboratory, Vanderbilt University Medical Center, D-2300 MCN, 1161 21st Ave. S., Nashville, TN 37232-2733. Phone: 615-322-5244; Fax: 615-322-6174; email: [email protected]
Received:
April 15 2003
Accepted:
May 22 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (3): 475–481.
Article history
Received:
April 15 2003
Accepted:
May 22 2003
Citation
Dan A. Dixon, Glen C. Balch, Nancy Kedersha, Paul Anderson, Guy A. Zimmerman, R. Daniel Beauchamp, Stephen M. Prescott; Regulation of Cyclooxygenase-2 Expression by the Translational Silencer TIA-1 . J Exp Med 4 August 2003; 198 (3): 475–481. doi: https://doi.org/10.1084/jem.20030616
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement